SCHEMBL2062264

SCHEMBL2062264

c1ccc2[nH]c(-c3ccncc3)cc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.71
RAB9A P51151 3/20 0.71
CYP19A1 P11511 1/20 0.67
KDM4E B2RXH2 3/20 0.62
MAPT P10636 2/20 0.62
CASP3 P42574 2/20 0.62
SENP8 Q96LD8 2/20 0.62
SENP7 Q9BQF6 2/20 0.62
SENP6 Q9GZR1 2/20 0.62
ALDH1A1 P00352 2/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2C9 P11712 1/20 0.62
HPGD P15428 1/20 0.62
CYP2C19 P33261 1/20 0.62
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29584517 1.00 NPC1 (0.71) NPC1RAB9ACYP19A1KDM4EMAPT
Indole SCHEMBL2062067 0.89 NPC1 (0.57) NPC1RAB9ACYP19A1KDM4EMAPT
SCHEMBL5053299 0.86 NPC1 (0.87) NPC1RAB9ACYP19A1KDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL29363616 0.84 NPC1 (1.00) NPC1RAB9ACYP19A1KDM4EMAPT
SCHEMBL28416625 0.84 NPC1 (0.83) NPC1RAB9ACYP19A1KDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL341378 0.84 NPC1 (1.00) NPC1RAB9ACYP19A1KDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL29642295 0.82 NPC1 (0.96) NPC1RAB9ACYP19A1KDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL11652520 0.82 NPC1 (0.96) NPC1RAB9ACYP19A1KDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL28371904 0.82 NPC1 (0.96) NPC1RAB9ACYP19A1KDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL6529483 0.82 NPC1 (0.96) NPC1RAB9ACYP19A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023162653-A1 RESIST UNDERLAYER FILM FORMATION COMPOSITION 日産化学株式会社 2023-08-31 WO disclosed
CN-113646301-A Antibacterial compounds and methods of use thereof 深圳大学 2021-11-12 CN disclosed
US-10023594-B2 Zwitterionic zinc(II) carboxylate compounds and their use MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (MO) 2018-07-17 US disclosed
US-10023594-B2 Zwitterionic zinc(II) carboxylate compounds and their use MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (MO) 2018-07-17 US disclosed
US-20180057512-A1 ZWITTERIONIC ZINC(II) CARBOXYLATE COMPOUNDS AND THEIR USE SOUTHERN MEDICAL UNIVERSITY (CN) 2018-03-01 US disclosed
US-20180057512-A1 ZWITTERIONIC ZINC(II) CARBOXYLATE COMPOUNDS AND THEIR USE SOUTHERN MEDICAL UNIVERSITY (CN) 2018-03-01 US disclosed
US-8148392-B2 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer LORUS THERAPEUTICS INC. (CA) 2012-04-03 US disclosed
US-8148392-B2 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer LORUS THERAPEUTICS INC. (CA) 2012-04-03 US disclosed
US-8148392-B2 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer LORUS THERAPEUTICS INC. (CA) 2012-04-03 US disclosed
WO-2011121629-A1 INDOLIC DERIVATIVES AND USE THEREOF IN MEDICAL FIELD UNIVERSITA' DEGLI STUDI DL ROMA "LA SAPIENZA" (IT) 2011-10-06 WO disclosed
US-20010020095-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-06 US disclosed
US-6262087-B1 HAVE HIGH AFFINITY FOR D4 RECEPTORS; USEFUL IN THE TREATMENT OF CERTAIN PSYCHIATRIC AND NEUROLOGIC DISORDERS, INCLUDING PSYCHOSIS, DEPRESSION AND ANXIETY. H. LUNDBECK A/S (DK) 2001-07-17 US disclosed
EP-1077213-A2 Inhibition of serotonin reuptake ELI LILLY AND COMPANY (US) 2001-02-21 EP disclosed
US-6046215-A A PIPERIDINYLBENZOTHIOPHENES USEFUL FOR TRATING BRAIN DISORDERS ELI LILLY AND COMPANY (US) 2000-04-04 US disclosed
CN-1246117-A 1, 2-indane or indoline derivatives LUNDBECK & CO AS H (DK) 2000-03-01 CN disclosed
EP-0946542-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1999-10-06 EP disclosed
US-5846982-A Inhibition of serotonin reuptake ELI LILLY AND COMPANY (US) 1998-12-08 US disclosed
WO-1998028293-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H.LUNDBECK A/S (DK) 1998-07-02 WO disclosed
WO-1997047302-A1 INHIBITION OF SEROTONIN REUPTAKE ELI LILLY AND COMPANY (US) 1997-12-18 WO disclosed
EP-0812826-A1 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake ELI LILLY AND COMPANY (US) 1997-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020095-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 NPC1 1119/4885RAB9A 2677/4885CYP19A1 474/4885
US-10023594-B2 Zwitterionic zinc(II) carboxylate compounds and their use ZC3HAV1, ZC3HAV1L, ZKSCAN2 NPC1 3017/4885RAB9A 4045/4885CYP19A1 4259/4885
US-20180057512-A1 ZWITTERIONIC ZINC(II) CARBOXYLATE COMPOUNDS AND THEIR USE ZC3HAV1, ZC3HAV1L, ZKSCAN2 NPC1 3017/4885RAB9A 4045/4885CYP19A1 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.